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The phenylacetic acid (PA) degradative pathway is the central pathway by which various
aromatic compounds (e.g., styrene) are degraded. Upper pathways for different aromatic
compounds converge at common intermediate phenylacetyl-CoA (PA-CoA), which is then
metabolized to succinyl-CoA and acetyl-CoA. We previously made a link in Burkholderia
cenocepacia between PA degradation and virulence by showing that insertional mutagen-
esis of paaA and paaE genes, that encode part of a multicomponent oxidase of PA-CoA,
results in PA-conditional growth and an attenuated killing phenotype in the Caenorhabditis
elegans model of infection. However, insertional mutagenesis of paaK1, which encodes a
phenylacetate-CoA ligase, did not result in a PA-conditional growth probably due to the pres-
ence of a putative paralog gene paaK2. Recently published crystallographic and enzyme
kinetics data comparing the two PaaK ligases showed that PaaK1 ismore active than PaaK2
and that the larger binding pocket of PaaK1 can accommodate hydroxylated PA derived
molecules such as 3-hydroxyphenylacetic (3-OHPA) acid and 4-hydroxyphenylacetic acid
(4-OHPA). The higher activity and broader substrate speciﬁcity suggested a more active
role in pathogenesis. In this work, we aimed to determine the relevance of PaaK1 activity
to the killing ability of B. cenocepacia to C. elegans. Using reporter activity assays, we
demonstrate that 3-OHPA activated PA degradation gene promoters of Burkholderia ceno-
cepacia K56-2 in a paaK1-dependent manner, while 4-OHPA had no effect. We compared
the pathogenicity of a paaK1 deletion mutant with that of the wild type in C. elegans and
observed no differences in the killing ability of the strains. Taken together, these studies
suggest that 3-OHPA, but not 4-OHPA, can induce the PA pathway and that this induction
is dependent on the paaK1 gene. However, the more active PaaK1 does not play a distinct
role in pathogenesis of B. cenocepacia as previously suggested.
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INTRODUCTION
The phenylacetic acid (PA) degradative pathway is a well-
conserved, central pathway in bacteria utilized in the breakdown
of many aromatic compounds such as styrene and phenylalanine
(Luengo et al., 2001). A unique feature of the PA degradation
pathway is that it exploits CoA activation of PA in aerobic condi-
tions. Thus, intermediates are processed as CoA thioesters that are
ﬁnally broken down into the TCA intermediates, acetyl-CoA, and
succinyl-CoA.
The detailed mechanism of the PA degradation pathway was
recently elucidated for E. coli K12 and Pseudomonas putida Y2
(Teufel et al., 2010; Figure 1A). The initial step is crucial as it con-
sists of the activation of PA by CoA mediated by the phenylacetate-
CoA ligase PaaK (Martinez-Blanco et al., 1990; El-Said Mohamed,
2000). In Burkholderia cenocepacia, the PA degradation genes are
organized in three clusters across two of three chromosomes
(Figure 1B). There are two similar yet non-identical genes that
encode phenylacetate-CoA ligases (Law et al., 2008). Each gene
(BCAL0404 or paaK1 and BCAM1711 or paaK2) is located on
chromosome 1 and chromosome 2 respectively. Recently, Law and
Boulanger (2011) provided a rationale for the presence of the
two-paralog PA-CoA ligases of B. cenocepacia by in vitro studies,
showing that PaaK1 has a much higher afﬁnity for PA than PaaK2
with Km values of 62 and 150μM, respectively. A striking differ-
encewas that PaaK1was able to accommodate 3′ and 4′ substituted
PA due to a larger binding pocket. Although both enzymes were
able to accept 3-OHPA, PaaK1 showed 6.5-fold greater afﬁnity for
3-OHPA than PaaK2. PaaK1 could also use 4-OHPA as substrate,
while the activity of PaaK2 with 4-OHPA was undetectable (Law
and Boulanger, 2011).
Wepreviously demonstrated that theB. cenocepacia K56-2 cata-
bolic pathway for phenylacetic acid (PA) degradation is a require-
ment for full pathogenesis of B. cenocepacia (Law et al., 2008) in the
Caenorhabditis elegans model of infection (Aballay and Ausubel,
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FIGURE 1 | Proposed PA degradation pathway for B. cenocepacia
J2315. (A) Detailed mechanism of the PA degradation pathway for E. coli
K12 and Pseudomonas putida Y2 (Teufel et al., 2010). (I) Phenylacetic
acid; (II) Phenylacetyl-CoA ligase; (III) ring 1,2-epoxyphenylacetyl-CoA;
(IV) 2-oxepin-2(3H)-ylideneacetyl-CoA; (V) 3-oxo-5,6-dehydrosuberyl-CoA;
(VI) 2,3-dehydroadipyl-CoA; (VII) 3-hydroxyadipyl-CoA; (VIII)
3-oxoadipyl-CoA; (IX) Acetyl-CoA; (X) succinyl-CoA. Enzymes: PaaK,
phenylacetyl-CoA ligase; PaaABCDE, Monooxygenase complex; PaaG,
ring 1,2-epoxyphenylacetyl-CoA isomerase/3,4-dehydroadipyl-CoA
isomerase; PaaZ, oxepin-CoA hydrolase/3-oxo-5,6-dehydrosuberyl-CoA
semialdehyde dehydrogenase; PaaJ, 3-oxoadipyl-CoA/3-oxo-5,
6-dehydrosuberyl-CoA thiolase; PaaF, 2,3-dehydroadipyl-CoA hydratase;
PaaH, 3-hydroxyadipyl-CoA dehydrogenase. (B) PA degradation gene
clusters of B. cenocepacia J2315. paaABCDE and paaFZJGIK1 are
located on the chromosome 1 and paaHK2paaG is located on
chromosome 2.
2002) but the role of the PaaK enzymes in pathogenicity and the
biological relevance of 3-OHPA and 4-OHPA as substrates was
not addressed. With the beneﬁt of reporter activity assays and C.
elegans as a host model organism, we aimed to address the rel-
evance of the more active and substrate-promiscuous PaaK1 for
pathogenesis of B. cenocepacia against C. elegans. We demonstrate
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that a hydroxylated PA derived molecule such as 3-OHPA can
induce the PA degradative pathway and that this induction is
paaK1-dependent. A clean deletion of paaK1 resulted however,
in wild type-like pathogenicity of B. cenocepacia in C. elegans.
MATERIALS AND METHODS
BACTERIAL STRAINS, NEMATODES, AND GROWTH CONDITIONS
Bacterial strains and plasmids are listed in Table 1. B. cenocepa-
cia strains were grown at 37˚C in Luria Bertani (LB), M9 media,
or modiﬁed nematode growth media (mNGM; 3 g L−1 NaCl,
17 g L−1 bacto-agar, 3.5 g L−1 peptone, 1 mL 5 mg mL−1 choles-
terol, 1 mL 1 M CaCl2, 1 mL 1 M MgSO4, 25 mL phosphate buffer)
supplemented, as required, with 100μg/mL trimethoprim (Tp),
and 200μg/mL chloramphenicol (Cm). Unless indicated other-
wise, glycerol and phenylacetic acid were added at 0.1% w/v and
5 mM, respectively. The nematode C. elegans, strain DH26 and E.
coli OP50 were obtained from the Caenorhabditis Genetics Center
(CGC), University of Minnesota, Minneapolis. C. elegans strains
were maintained on nematode growth media (NGM) according
to standard practices at the CGC.
MOLECULAR BIOLOGY TECHNIQUES
E. coli DH5α cells were transformed using the calcium chloride
protocol (Cohen et al., 1972) and electroporation was used for
transformationof E. coli SY327 cells (Miller andMekalanos,1988).
Conjugation into B. cenocepacia K56-2, and IAI1 was accom-
plished by tri-parental mating (Craig et al., 1989) with E. coli
DH5α carrying the helper plasmid pRK2013 (Figurski and Helin-
ski, 1979).DNAwas ampliﬁed using anEppendorf Mastercycler ep
gradient S thermal cycler with TaqDNApolymerase PCRKit (Qia-
gen). Ampliﬁcation conditions were optimized for each primer
pair. PCR products and plasmids were puriﬁed with QIAquick
puriﬁcation kit (Qiagen) and QIAprep Miniprep kit (Qiagen),
respectively.
CONSTRUCTION OF paak1 DELETION MUTANT IAI1
IAI1 (paaK1) was created using the techniques outlined in Flan-
nagan et al. (2008) using B. cenocepacia wild type K56-2. Brieﬂy,
introduction of plasmid pRL5 (Table 1), which contains the ﬂank-
ing regions of paaK1 as well as a yeast I-SceI restriction site
(TAGGGATAACAGGGTAAT)was performedby tri-parentalmat-
ing. The ﬁrst homologous recombination event and the recom-
bination site were conﬁrmed by colony PCR with primer pairs
154/165 or 153/164 (Table 2), which anneal to the plasmid and
the genome, respectively. Following homologous recombination
a second plasmid pDAI-SceI, which constitutively expresses the
yeast homing endonuclease I-SceI, was introduced by tri-parental
mating. Resulting clones were screened for trimethoprim sensi-
tivity and tetracycline resistance by replica plating on LB con-
taining 100μg/mL of tetracycline with and without 100 μg/mL of
trimethoprim. Subsequently, trimethoprim sensitive clones were
screened for the deletion of paaK1 with primers 166 and 167
(Table 2). Following conﬁrmation by colony PCR that the gene
had been deleted, pDAI-SceI was cured by serial dilution in LB
broth. Loss of the plasmid was conﬁrmed by colony PCR using
primers 3 and 4, which anneal external to the multi-cloning site of
pDAI-SceI. Deletion of the paaK1 in B. cenocepacia IAI1 gene was
further conﬁrmed by sequencing.
BACTERIAL GROWTH
One-milliliter aliquots of M9 plus different carbon sources were
inoculated with 100μL from overnight culture grown in LB,
Table 1 | Bacterial strains and plasmids.
Strain or plasmid Features Reference or source
E. COLI STRAINS
DH5α F-_Φ80 lacZΔ M15 endA1 recA1 hsdR17 (rK-mK+) supE44 thi -1Δ gyrA96 (ΔlacZYAarg-F )
U169 relA1
Invitrogen
SY327 A(lac pro) argE(Am) rif 20 nalA recA56 Miller and Mekalanos (1988)
MM290 Host strain for pRK2013 Izard et al. (1992)
B. CENOCEPACIA STRAINS
K56-2 ET12 clone related to J2315, CF clinical isolate Mahenthiralingam et al. (2000)
IAI1 K56-2paak1 This study
STC179 (paaA) K56-2::pGPomegaTp paaA, Tpr Law et al. (2008)
STC155 (paaE ) K56-2::pGPomegaTp paaE, Tpr Law et al. (2008)
PLASMIDS
pRL5 pGPISceI, paaK1 ﬂanking regions Law (2009)
pJH1 DHFR promoter controlling e-gfp Hamlin et al. (2009)
pJH2 Promoterless e-gfp Hamlin et al. (2009)
pJH6 paaZ promoter controlling e-gfp Hamlin et al. (2009)
pJH7 paaA promoter controlling e-gfp Hamlin et al. (2009)
pJH8 paaH promoter controlling e-gfp Hamlin et al. (2009)
pDAI-SceI Constitutive expression vector, oricolE1, DHFR promoter, Tcr, I-SceI Aubert et al. (2008)
pRK2013 oricolE1, RK2 derivative, Kmr mob+ tra+ Figurski and Helinski (1979)
Cm, chloramphenicol; Tp, trimethoprim; CF, cystic ﬁbrosis.
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washed with PBS, and adjusted to an optical density at 600 nm
(OD600) of 2.0. One hundred ﬁfty microliters aliquots were added
in triplicate to 96-well format plates and the microplates were
incubated 24 h at 37˚C with shaking at 210 rpm. Growth was mea-
sured as the OD600 was measured with a BioTek Synergy 2 plate
reader at hourly intervals.
NEMATODE INFECTION ASSAYS
Caenorhabditis elegans slow killing assays were performed as pre-
viously described (Law et al., 2008). Thirty 5 mm plates ﬁlled
with mNGM were seeded with 50μL of stationary phase cul-
ture adjusted to an OD600 of 1.7. In these growth conditions,
the PA degradation pathway is activated. Plates were incubated
overnight at 37˚C to allow growth of a bacterial lawn before 30–
40 hypochlorite-synchronized L4 larvae of C. elegans DH26 were
inoculated to each plate and plates were then incubated at 25˚C for
the duration of the experiment. Plates were scored for live worms
at the time of inoculation and every 24 h subsequently for 7 days
using a stereo-master dissecting microscope. Worms were consid-
ered dead when unresponsive to touch with a sterile wire pick.
Assays were performed in triplicate and analyzed using survival
curves generated by the Kaplan–Meier statistical method. The log
rank test was used to compare survival differences for statistical
signiﬁcance using GraphPad Prism, version 5.02. A P value<0.05
was considered to be signiﬁcant.
REPORTER ACTIVITY ASSAYS
Green Fluorescent Protein ﬂuorescence was measured accord-
ing to its excitation/emission wavelengths of 488/509 (Cormack
et al., 1996). Relative ﬂuorescence, deﬁned as the ratio between
arbitraryﬂuorescence andOD600 wasmeasuredwith aBioTekSyn-
ergy 2 plate reader, using excitation 485/20 and emission 528/20
ﬁlter sets.
Table 2 | Primers.
Name Oligonucleotide sequence Purpose
SC003 GGCGTAGAGGATCTGCTCATGTTTG External to MCS in
pDAI-SceI, forward
SC004 GCTACTGCCGCCAGGCAAATTCTGT External to MCS in
pDAI-SceI, reverse
SC137 CCAGTTCTAGACGTTCGAGCAGTTTCATCCA paaK1 upstream
forward
SC140 CATTTGATATCGAGGCGTTCTTCCTGCA paaK1 downstream
reverse
SC153 GTGGATGACCTTTTGAATGACCTTT External to MCS in
pRL5 forward
SC154 ACAGGAACACTTAACGGCTGACATG External to MCS in
pRL5, reverse
SC166 GCGTGCAACTCGTACAACCTGAGTG paaK1 upstream
forward
SC167 CGGATGTGGCTGCTGTTCCCGAATT paaK1 downstream
reverse
SC172 GAGACACATATGACTACCCCGCTACCGCT paaK1 5′
SC173 AACGTCTAGATCAGCCCTTGCGCTTGTCGA paaK1 3′
Restriction sites are underlined.
RESULTS
BURKHOLDERIA CENOCEPACIA UTILIZES 3-OHPA AND 4-OHPA AS SOLE
CARBON SOURCES, BUT NOT EXCLUSIVELY THROUGH PA
DEGRADATION
To address the biological relevance of 3-OHPA and 4-OHPA as
substrates of the PaaK enzymes,we started out by asking if B. ceno-
cepacia could use 3-OHPA and 4-OHPA as sole carbon sources.
Given the evidence that 3-OHPA and 4-OHPA can be substrates
of the PaaK enzymes (Law and Boulanger, 2011) we also consid-
ered that these compounds could be funneled exclusively through
the PA catabolic pathway. B. cenocepacia K56-2 was grown in 3-
OHPAor 4-OHPAas sole carbon sources and growthwas recorded
as ﬁnal optical density. The hydroxylated phenolic acids supported
80 and 54% growth related to growth in glucose, respectively while
3-OHPA and 4-OHPA supported growth to 94 and 75% respec-
tively, in comparison to growth in PA (Figure 2). Similarly, the
paaK1 deletion mutant IAI1 did not show any growth-defective
phenotype in PA according to the presence of a second paaK gene
(paaK2). Moreover, deletion of the paaK1 gene did not affect the
ability of this strain to use 3-OHPA or 4-OHPA (87% and 80%
growth related to glucose, respectively). Concomitantly, when the
PA degradation defective mutants PaaA and PaaE were grown
with 3-OHPA, 4-OHPA, or PA the growth-defective phenotype
was observed only in the presence of PA (3.4 and 4% growth,
respectively) while both mutants exhibited wild type-like growth
in the presence of the hydroxylated phenolic acids. This suggests
that 3-OHPA and 4-OHPA are degraded through other routes,
possibly the homogentisate and homoprotocatechuate pathways
(Méndez et al., 2011). Taken together, these results suggest that 3-
OHPA and 4-OHPA can serve as carbon sources for B. cenocepacia
and that these compounds do not seem to be degraded exclusively
through the PA degradative pathway.
3-OHPA BUT NOT 4-OHPA INDUCES THE PA DEGRADATIVE PATHWAY
We reasoned that 3-OHPA and 4-OHPA, as substrates for
PaaK1, could induce the PA degradative pathway in Burkholderia
FIGURE 2 | Growth of B. cenocepacia strains with 3-OHPA, 4-OHPA as
sole carbon sources. B. cenocepacia K56-2 (wild type), deletion mutant
IAI1 (paaK1), and insertional mutants STC179, (paaA) and STC155 (paaE)
were grown for 24 h in M9 media supplemented with 5mM PA, 3-OHPA,
4-OHPA, or 0.2% glucose as sole carbon sources. Error bars represent the
SD of three replicates.
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cenocepacia. In order to test this, we utilized a PA pathway induc-
tion reporter assay previously developed in our laboratory (Ham-
lin et al., 2009). The translational reporter consists of a plasmid
with the enhanced green ﬂuorescent protein gene (e-gfp) con-
trolled by the paa promoter for each of the three paa gene clusters
of the B. cenocepacia paa operons that start with the paaZ, paaA,
and paaH genes. Growth of a strain carrying the reporter plasmid
in minimal media with PA results in expression of eGFP,which can
be measured by ﬂuorescence as an indication of the induction of
the PApathway. Plasmids pJH1 andpJH2 carry e-gfp under control
of the constitutive expression promoter DHFR and a promoterless
e-gfp, respectively.
Burkholderia cenocepacia K56-2 reporter strains were grown in
M9 minimal media with glycerol supplemented with 5 mM PA,
3-OHPA, or 4-OHPA (Figure 3). After 24 h of incubation at 37˚C
the relative ﬂuorescence of wild type and reporter strains was ana-
lyzed. Low levels of background ﬂuorescence were observed for
B. cenocepacia K56-2 wild type and the reporter strain carrying
a promoterless e-gfp gene. On the contrary, when B. cenocepa-
cia/pJH1 was grown with glycerol or glycerol plus phenolic acids,
increased ﬂuorescence was observed. The levels of relative ﬂuores-
cence due to PA,3-OHPA,or 4-OHPAwere comparable suggesting
that there are no metabolic effects of these compounds on plasmid
copynumber.WhenPApathway reporter strainswere grown in the
presence of PA, an increase in relative ﬂuorescence was observed as
previously described. However, only 3-OHPA (but not 4-OHPA)
was capable of inducing the paaZ, paaA, and paaH promoters
(Figure 2). Across the board, we noted an average of ﬁve times less
relative ﬂuorescence in media containing 4-OHPA than in media
containing PA. Interestingly,B. cenocepacia K56-2/pJH6 registered
a twofold increase in relative ﬂuorescence for 3-OHPA in compar-
ison with PA (7389 and 4281, respectively). However, this was not
the case for B. cenocepacia K56-2 harboring pJH7 or pJH8. These
strains showed slightly higher relative ﬂuorescence in response to
PA in comparison with 3-OHPA (11206 and 9966 units, respec-
tively for pJH7 and 4454 and 3502 units, respectively for pJH8).
For all carbon sources tested, pJH7 registered a phenotype charac-
terized with strongest levels of relative ﬂuorescence compared to
the other reporter strains, as described previously (Hamlin et al.,
2009).
INDUCTION OF PA DEGRADATION BY 3-OHPA IS DEPENDENT ON THE
paak1 GENE
To shed light on the role of paaK1 gene in the induction of PA
degradation by 3-OHPA, we constructed a B. cenocepacia K56-2
paaK1 deletion mutant, IAI1 and introduced the reporter plasmid
pJH7 in this strain. Next, we compared the relative ﬂuorescence of
the reporter system in the paaK1 genetic background to the one
in the wild type upon induction by 3-OHPA. Figure 4 shows an
increase in relative ﬂuorescence in the presence of PA in both wild
type and IAI1 reporter strains. This is expected due to the presence
of at least one functioning paaK gene. It is probable then, that the
PaaK2 enzyme is able to synthesize PA-CoA, which is necessary to
activate the paa promoters (Yudistira et al., 2011). Nevertheless,
compared to K56-2/pJH7, IAI/pJH7 exhibited 10% less ﬂuores-
cence possibly due to the presence of two functioning ligases in
the wild type variant compared to one in the mutant. K56-2/pJH7
FIGURE 3 | B. cenocepacia K56-2 reporter activity assays. PA pathway
induction in B. cenocepacia K56-2 (wild type) measured as relative
ﬂuorescence at 12 h. Strains were grown in M9 minimal media with PA,
3-OHPA, or 4-OHPA (plus 0.1% glycerol) or 0.2% glycerol. pJH7, paaA
promoter reporter; pJH8, paaH promoter reporter; pJH6, paaZ promoter
reporter; pJH1, positive control; pJH2, negative control. Error bars
represent the SD of three replicates.
FIGURE 4 | paaK1 reporter activity assays. paaA promoter induction in B.
cenocepacia K56-2 (wild type) and B. cenocepacia deletion mutant IAI1
(paaK1) measured as relative ﬂuorescence at 12 h. Strains were grown in
M9 minimal media with PA, 3-OHPA, or 4-OHPA (plus 0.1% glycerol) or
0.2% glycerol. pJH7, paaA promoter reporter plasmid. Error bars represent
the SD of three replicates.
registered induction of the PA degradative pathway in 3-OHPA,
(but not 4-OHPA) converse to IAI1/pJH7,which did not for either
carbon source. We can therefore deduce that induction of the PA
degradative pathway by 3-OHPA is dependent on the presence of
PaaK1 and not PaaK2.
PaaK1 DOES NOT PLAY A ROLE IN B. CENOCEPACIA PATHOGENICITY
Previous preliminary work done by Law (2009) in our labora-
tory had suggested that a paaK1 deletion mutant in B. cenocepacia
K56-2 (RJL1) resulted in an attenuated phenotype in C. elegans.
However, introduction of a paaK1 gene in trans in this strain did
not restore the phenotype towild type levels (data not shown) sug-
gesting that the attenuated phenotypewas not related to paaK1 but
to a secondary site mutation.
In order to ﬁnally elucidate the role of PaaK1 in pathogenicity,
we conducted slow killing assays with the paaA strain as a con-
trol of attenuated pathogenicity (Figure 5A) and with the newly
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FIGURE 5 | Nematode slow killing assays. Kaplan–Meier Survival curve
comparing killing phenotypes of (A) B. cenocepacia wild type strain K56-2
(n =68; solid line) and insertional mutant, paaA (n =74; broken line); P
value<0.0001 (S) and (B) B. cenocepacia wild type strain K56-2 (n =113;
solid line) and paaK1 deletion mutant, IAI1 (n =110; broken line); P
value=0.063 (NS).
constructed deletion mutant IAI1 (Figure 5B). Survival of the
worms exposed to the wild type strain, K56-2, registered a sharp
drop by more than 75% on day 2 of the assay with complete loss
of survival at day 4. For worms infected with IAI1, a 50% drop
in survival occurred on day 1 followed by a wild type-like decline
in survival in subsequent days. Overall, we found no signiﬁcant
difference (P value= 0.063) in pathogenicity between wild type
and paaK1 mutant. This ﬁnding supports a strong likelihood that
PaaK1 may not play a role in PA pathway related killing.
DISCUSSION
The premise that PaaK1, the activating enzyme of the PA path-
way, can also bind 3-OHPA and 4-OHPA (Law and Boulanger,
2011) suggests that these phenolic acids may also be involved in
inducing the pathway particularly 3-OHPA which binds PaaK1
with a lower Km than 4-OHPA. We supported this assertion with
the results from our reporter activity assays showing PA pathway
induction in minimal media containing 3-OHPA. Of particularly
note is the observation that the strain harboring reporter plasmid
(pJH6), featuring the paaZ promoter, displays double the strength
of induction in 3-OHPA than in PA unlike the other two reporter
plasmids (pJH7 and pJH8), which register only slightly stronger
induction in PA. This is noteworthy because paaK1 is downstream
of and under the control of the paaZ promoter. More interest-
ingly, the gene upstream of paaK1 is the paaI gene, which encodes
a hotdog thioesterase PaaI that preferentially binds 3-OHPA-CoA
and 4-OHPA-CoA as substrates compared to PA-CoA (Song and
Ko, 2007).
In toto, our results show that 3-OHPA induces the PA degrada-
tive pathway whereas 4-OHPA does not and that this induction
is dependent on the presence of a functional paaK1 gene. Thus,
we provide in vivo evidence for the role of 3-OHPA as a substrate
of PaaK1 in Burkholderia cenocepacia, while 4-OHPA is likely not
physiologically relevant as a substrate of PaaK1.
The basis of this study was preliminary data showing that a
deletion of the paaK1 gene in B. cenocepacia RJL1 resulted in an
attenuated killing phenotype in the nematode host model (Law,
2009). According to this ﬁnding, Law and Boulanger (2011) sug-
gested that the more active, and substrate-versatile PaaK1 might be
more beneﬁcial during infection. However, our results show that
PaaK1 (and possibly 3-OHPA as a PA degradation inducer) does
not play a signiﬁcant role in pathogenicity.
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